A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice

Journal of Thoracic Disease

Volumn 6, Issue 6, 2014, Pages 625-631

  Kim, Cheol Hong ^a   Woo, Heungjeong ^a   Hyun, In Gyu ^a   Kim, Changhwan ^a   Choi, Jeong Hee ^a   Jang, Seung Hun ^a   Park, Sang Myeon ^a   Kim, Dong Gyu ^a,b   Lee, Myung Goo ^a   Jung, Ki Suck ^a   Hyun, Jeongwon ^a   Kim, Hyun Soo ^a  

^a Hallym University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Mycobacterium tuberculosis (MTB); Polymerase chain reaction (PCR); Pulmonary tuberculosis

Indexed keywords

ACID FAST BACTERIUM; ARTICLE; BACTERIUM CULTURE; BLOOD SMEAR; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG SENSITIVITY; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NESTED POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PREVALENCE; PUBLIC HEALTH; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; XPERT MTB/RIF ASSAY;

EID: 84904858625     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2014.04.12     Document Type: Article

References (25)

1. WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries. Available online: https://extranet.who.int/sree/ Reports?op=Replet&name=%2FWHO_HQ_Reports%2F G2%2FPROD%2FEXT%2FTBCountryProfile&ISO2= KR&LAN=EN&outtype=html
2. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009;58:7-10.
3. Jouveshomme S, Cambau E, Trystram D, et al. Clinical utility of an amplification test based on ligase chain reaction in pulmonary tuberculosis. Am J Respir Crit Care Med 1998;158:1096-101.
4. Piersimoni C, Scarparo C, Piccoli P, et al. Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens. J Clin Microbiol 2002;40:4138-42.
5. Hasegawa N, Miura T, Ishii K, et al. New simple and rapid test for culture confirmation of Mycobacterium tuberculosis complex: a multicenter study. J Clin Microbiol 2002;40:908-12.
6. Magdalena J, Vachee A, Supply P, et al. Identification of a new DNA region specific for members of Mycobacterium tuberculosis complex. J Clin Microbiol 1998;36:937-43.
7. WHO (2013). Global tuberculosis report.
8. Bai GH, Park YK, Choi YW, et al. Trend of antituberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007;11:571-6.
9. El-Hajj HH, Marras SA, Tyagi S, et al. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001;39:4131-7.
10. Tyagi S, Kramer FR. Molecular beacons in diagnostics. F1000 Med Rep 2012;4:10.
11. Pai M, Minion J, Sohn H, et al. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009;30:701-16, viii.
12. Van Deun A, Martin A, Palomino JC. Diagnosis of drugresistant tuberculosis: reliability and rapidity of detection. Int J Tuberc Lung Dis 2010;14:131-40.
13. Yang XY, Li YP, Mei YW, et al. Time and spatial distribution of multidrug-resistant tuberculosis among Chinese people, 1981-2006: a systematic review. Int J Infect Dis 2010;14:e828-37.
14. Aryan E, Makvandi M, Farajzadeh A, et al. Clinical value of IS6110-based loop-mediated isothermal amplification for detection of Mycobacterium tuberculosis complex in respiratory specimens. J Infect 2013;66:487-93.
15. Aryan E, Makvandi M, Farajzadeh A, et al. A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex. Microbiol Res 2010;165:211-20.
16. Singh A, Kashyap VK. Specific and Rapid Detection of Mycobacterium tuberculosis Complex in Clinical Samples by Polymerase Chain Reaction. Interdiscip Perspect Infect Dis 2012;2012:654694.
17. Chang K, Lu W, Wang J, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012;64:580-8.
18. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol;48:229-37.
19. Morehead RS. Tuberculosis of the pleura. South Med J 1998;91:630-6.
20. Bastian I, Rigouts L, Van Deun A, et al. Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required? Bull World Health Organ 2000;78:238-51.
21. Bunsow E, Ruiz-Serrano MJ, López Roa P, et al. Evaluation of GeneXpert MTB/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampin in clinical specimens. J Infect 2014;68:338-43.
22. Das S, Paramasivan CN, Lowrie DB, et al. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber Lung Dis 1995;76:550-4.
23. Kent L, McHugh TD, Billington O, et al. Demonstration of homology between IS6110 of Mycobacterium tuberculosis and DNAs of other Mycobacterium spp.? J Clin Microbiol 1995;33:2290-3.
24. Kwak N, Choi SM, Lee J, et al. Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice. PLoS One 2013;8:e77456.
25. Choi JC, Lim SY, Suh GY, et al. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. J Korean Med Sci 2007;22:677-81.